Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Market Closed - Nasdaq
Other stock markets
 02:00:00 21/05/2024 am IST 		5-day change 1st Jan Change
0.6359 USD +2.38% Intraday chart for Galecto, Inc. -6.50% -11.68%
01/05 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI
29/04 Galecto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GALECTO, INC. Stock Galecto, Inc.
 1.68Cr - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 11TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
ARGENX SE Stock argenx SE
 2.2TCr -
BIONTECH SE Stock BioNTech SE
 2.19TCr -
GENMAB A/S Stock Genmab A/S
 1.92TCr
  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Charts Galecto, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW